Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440518
Status:
COMPLETED
Last Update Posted:
2018-07-17
First Post:
2007-02-23
Brief Title:
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Sponsor:
UCB Pharma
Organization:
UCB Pharma
Study Overview
Official Title:
A Multicenter Randomized Double-blind Placebo-controlled Trial to Assess the Efficacy and Safety of 100mgDay and 300mgDay Lacosamide for Migraine Prophylaxis
Status:
COMPLETED
Status Verified Date:
2017-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
True
If Expanded Access, NCT#:
NCT03559673
Has Expanded Access, NCT# Status:
NO_LONGER_AVAILABLE
Acronym:
SP906
Brief Summary:
The purpose of this study is to see how safe and effective Lacosamide LCM is when taken by mouth twice a day for up to 18 weeks to prevent migraines
Detailed Description:
This study is for subjects who have been diagnosed with migraine for at least one year and who are currently taking an effective abortive medications
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None